Riesenzellarteriitis - Wege Zur Precision Medicine
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age greater or similar to 18 years
• Primary diagnosis of GCA or PMR
Locations
Other Locations
Germany
Universitätsklinikum Würzburg
RECRUITING
Würzburg
Contact Information
Primary
Michael Gernert
gernert_m1@ukw.de
+4993120140100
Backup
Hannah Labinsky
Labinsky_h@ukw.de
+4993120140100
Time Frame
Start Date: 2025-11-14
Estimated Completion Date: 2033-07-31
Participants
Target number of participants: 400
Treatments
Known patients
Patients, who are already known and had regular visits in the outpatient rheumatology department of the Würzburg university hospital. These patients already receive immunosuppressive therapy.
New patients
Patients who have not yet been treated by the outpatient rheumatology department of the Würzburg university hospital, preferably but not limited to immunosuppressive therapy-naive patients.
Related Therapeutic Areas
Sponsors
Leads: Wuerzburg University Hospital